Recommended Conferences

  • Annual Conference on Bacterial Viral and Infectious Diseases
    August 06-08, 2018,Abu Dhabi,UAE
  • Annual Meeting on Infectious Diseases
    Theme: Infectious Diseases and Global Health: Cutting Edge Researches
    August 20-21, 2018,Prague,Czech Republic
  • 12th Annual Meet on Bacteriology & Applied Microbiology
    Theme: Innovative Research in Bacteriology and Applied Microbiology
    August 20-21, 2018,Singapore City,singapore
  • International Conference on Bacteriology and Infectious Diseases
    September 17-19, 2018,Cape Town,South Africa
  • 14th World Conference Infectious Diseases, Prevention and Control
    October 15-16, 2018. Abu Dhabi,UAE

Luis Ulloa

Luis Ulloa Luis Ulloa
Department of Surgery at New Jersey Medical School, Rutgers University, USA
Dr. Luis Ulloa is a Professor in the Department of Surgery at New Jersey Medical School, Rutgers University, USA. He graduated and acquired his PhD from the University of Madrid work in neuronal neurodegeneration in Alzheimer's disease. He completed his postdoctoral training in the Lab of Dr. Massague at the Memorial Sloan Cancer Center, NY. He studied the regulation of the TGF-beta signaling pathway by inflammatory signals such as the interferon-gamma. He joined North Shore University Hospital, NY, where he started to work on the anti-inflammatory potential of the vagus nerve and the cholinergic receptors controlling macrophages activation and inflammation in sepsis. He moved to the Rutgers New Jersey Medical School in 2007. He has received prestigious scientific awards and has published over 70 peer-review articles in the most prestigious scientific journals. He has been invited to write multiple review and editorial articles. His studies are funded by the department of Defence, American Heart Association, and the NIH.
Research Interest
Dr. Luis Ulloa research focused on the anti-inflammatory potential of the nervous system to control systemic inflammation and organ damage in critical care including trauma, hemorrhage, infectious diseases and inflammatory disorders including sepsis. Currently he is studying the physiological, cellular and molecular mechanisms directing Neuromodulation and their potential clinical translation for the treatment of infectious and inflammatory disorders. He has a special interest in the pathogenesis of Sepsis, a leading cause of death in hospitalized patients.

Relevant Conferences